News
BDRX
0.7675
-0.45%
-0.0035
Biodexa Pharmaceuticals Secures $5M Funding
TipRanks · 3d ago
Biodexa Pharmaceuticals plc: Prospectus [Rule 424(b)(3)]
Press release · 4d ago
Weekly Report: what happened at BDRX last week (0715-0719)?
Weekly Report · 4d ago
Biodexa Pharmaceuticals Unveils Series J Warrant
TipRanks · 07/19 13:28
Biodexa Pharmaceuticals announces pricing of $5M registered direct offering
Biodexa Pharmaceuticals announces pricing of $5M registered direct offering. The gross proceeds from the offering are expected to be approximately $5.0 million. Biodex a Pharmaceuticals PLC (NASDAQ:BDRX) announced the offering of ADSs and warrants.
Seeking Alpha · 07/19 12:52
Biodexa Pharmaceuticals Announces Pricing Of $5M Registered Direct Offering And Concurrent Private Placement
Benzinga · 07/19 12:32
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Barchart · 07/19 07:30
How Is The Market Feeling About Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals's short percent of float has fallen 35.68% since its last report. The company has 140 thousand shares sold short, which is 1.55% of its float. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 07/16 18:45
Biodexa Pharmaceuticals plc: [Cover]SEC-generated letter
Press release · 07/16 16:06
Biodexa’s Diabetes Drug Enters Phase 2a Studies
TipRanks · 07/16 13:18
Weekly Report: what happened at BDRX last week (0708-0712)?
Weekly Report · 07/15 11:04
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
ASP Isotopes Inc. Shares fell 9.2% to $3.2308 on Friday. The company announced pricing of a $30 million public offering of 12 million shares at $2.50 per share. Vicinity Motor Corp. Shares jumped 133.2%. Other stocks moving in today's mid-day session.
Benzinga · 07/12 17:15
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Crown LNG stock is rocketing almost 154% after completing a business combination. Crown LNG is one of 10 top pre-market stock movers to watch on Friday morning. The biggest pre- market stocks to watch are mergers, clinical trial data, public offerings and more.
Investorplace · 07/12 11:41
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Telefonaktiebolaget LM Ericsson shares rose sharply in today's pre-market trading. The company reported better-than-expected second-quarter sales and issued guidance. Sentage Holdings Inc. Shares rose 85.6% to $4.27 after surging 85% on Thursday.
Benzinga · 07/12 09:35
Gold Rises Sharply; Methode Electronics Shares Spike Higher
U.S. Stocks traded mostly lower toward the end of trading on Thursday. The Nasdaq Composite dipped 2% and the Dow traded up 0.07%. Real estate shares jumped by 2.4% on Thursday; information technology shares fell 2.7%. Delta Air Lines, Inc. Posted downbeat second-quarter earnings and issued lower-than-expected third-quarter outlook. Asian markets closed mostly higher; European shares closed higher today.
Benzinga · 07/11 18:35
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Conagra Brands, Inc. Shares fell 3.9% to $27.70 on Thursday. The company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below estimates. Kazia Therapeutics Limited shares surged 88.6% in the mid-day session. Biodexa Pharmaceuticals Plc shares jumped 78.6%.
Benzinga · 07/11 18:02
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
Joby Aviation (NYSE:JOBY) stock is up 16% on Thursday after completing a massive 523-mile-long eVTOL flight. The electric vertical takeoff and landing (eVTOL) company reported a new milestone for its aircraft. Joby Aviation completed the flight with an aircraft running off of a combination of electricity and hydrogen.
Investorplace · 07/11 16:51
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Biodexa Pharmaceuticals PLC announced progress on eRapa, its drug to treat Familial Adenomatous Polyposis (FAP) 12-month data from a phase 2 clinical trial showed a reduction in the number of precancerous polyps. The drug slows down the mTOR protein, which is linked to cancer.
Benzinga · 07/11 16:44
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
Kazia Therapeutics (NASDAQ:KZIA) stock is continuing to rally on Thursday after the company reported positive clinical trial data yesterday. The company’s shares are up 123.3% since the start of the year. KZIA stock continues to see heavy trading on Thursday with more than 182 million shares on the move. InvestorPlace has all of the latest stock market news for you on Thursday.
Investorplace · 07/11 16:31
More
Webull provides a variety of real-time BDRX stock news. You can receive the latest news about Biodexa Pharmaceuticals plc through multiple platforms. This information may help you make smarter investment decisions.
About BDRX
Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.